Pomalidomide Capsule
Product Images NDC 31722-772

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 31722-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg21countcontainerlabel (1mg21countcontainerlabel)

The text contains information regarding a medication called pomalidomide, with each capsule containing 1 mg of the active ingredient. It provides instructions on storage conditions, dosage, and administration. Additionally, it warns about the potential for human birth defects and emphasizes the importance of keeping the medication out of reach of children. The medication guide is available at a provided website, and the pharmacist is instructed to dispense the medication guide to each patient. The medication is manufactured by Hetero Labs Limited in India.*

FDA Label Image

2mg21countcontainerlabel (2mg21countcontainerlabel)

Each capsule contains 2 mg of pomalidomide. It is recommended to store the capsules at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication has a WARNING about the potential for human birth defects, and a Medication Guide is available online. The product is manufactured by HETERO™ and dispensed by pharmacists. The manufacturer is Hetero Labs Limited in India.*

FDA Label Image

3mg21countcontainerlabel (3mg21countcontainerlabel)

This text contains information about "CAMBER" Pomalidomide Capsules, including a warning about potential human birth defects, dosage instructions, storage guidelines, contact information, and manufacturing details. It also advises pharmacists to dispense a medication guide to each patient. The capsules contain 3 mg of pomalidomide and should be stored at 20°C to 25°C. More information can be found in the prescribing information and the medication guide available at camberpharma.com/medication-guides.*

FDA Label Image

4mg21countcontainerlabel (4mg21countcontainerlabel)

Each capsule contains 4 mg of pomalidomide. The usual dosage can be found in the prescribing information. Store between 20°C to 25°C (68°F to 77°F) with excursions to 15°C to 30°C (59°F to 86°F) allowed. Keep out of reach of children. There is a warning about the potential for human birth defects. A medication guide is available at the provided website. Contact number: 1-866-495-1995. Manufactured by HETERO™ for Hetero Labs Limited in India. Package size: 21 capsules. Pharmaceutical information including manufacturer address is available on the label.*

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Table3 (Table3)

This text lists various adverse reactions observed in patients receiving Pomalidomide treatment, categorized by body system. Some of the reactions include blood and lymphatic system disorders, general disorders like fatigue and edema, gastrointestinal disorders like nausea and constipation, musculoskeletal and connective tissue disorders like back pain and muscle spasms, infections like pneumonia and urinary tract infection, and metabolic disorders like decreased appetite and hypercalcemia. These insights can be valuable for healthcare professionals in monitoring and managing the side effects of Pomalidomide therapy.*

FDA Label Image

Table4 (Table4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.